We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

FUJIREBIO

Fujirebio is a global leader in the field of IVD testing with more than 50 years’ experience in the conception, devel... read more Featured Products: More products

Download Mobile App




Rare Parasite Causes Relapsing Febrile Myositis

By LabMedica International staff writers
Posted on 19 Jun 2014
Sarcocystis species are protozoan organisms that have been associated with disease in animals but less frequently so in humans, where symptoms such as myalgia, muscle weakness and transitory edema may occur. More...


Humans can become hosts for Sarcocystis species by consuming food or water contaminated with fecal sporocysts from an infected definitive host and in such cases, hematogenous dissemination can occur with invasion of muscle leading to sarcocysts.

Scientists at the University of Malaya (Kuala Lumpur, Malaysia) investigated an outbreak of acute, relapsing febrile myositis that occurred in a group of 92 college students and teachers that had attended a retreat in a hotel located on Pangkor Island, off the west coast of Peninsular Malaysia. Investigations included full blood counts (FBC), renal function tests (RFT), liver function tests (LFT), serum creatine kinase (CK) levels, chest X-rays, blood cultures, and blood films for malarial parasites.

Serological testing was done for Chikungunya virus, Dengue virus, Legionella, Mycoplasma, and Leptospira. Testing was performed using an in-house immunofluorescence assay for detection of chikungunya immunoglobulin M (IgM) and IgG; anti-dengue IgM and IgG capture ELISA (Standard Diagnostics; Yongin, Korea) for detection of dengue IgM and IgG; immunofluorescence assays for detection of Legionella IgG (MarDx Diagnostics, Inc.; Bray, Ireland) and Legionella IgM (Vircell; Granada, Spain); SERODIA-MYCO II (Fujirebio Inc.; Tokyo,Japan) for detection of Mycoplasma total antibodies.

Sarcocystis serology was done by an immunoblot assay using S. neurona merozoite-derived antigens (Centers of Disease Control; Atlanta, GA, USA) in 10 patients. Muscle biopsies from affected sites in four patients with myalgia and Magnetic resonance imaging (MRI) abnormalities were fixed in buffered 10% formalin and routinely processed. Hematoxylin and eosin stained tissue sections were examined by light microscopy. Polymerase chain reaction (PCR) for Sarcocystis spp. was performed on all four biopsies.

Out of four muscle biopsies, sarcocysts were identified in three. S. nesbitti was identified by PCR in three of the four biopsies including one biopsy without an observed sarcocyst. Non-Malaysians had a median duration of symptoms of 27.5 days which was longer than that of 14 days for Malaysians, and the Non-Malaysians were more likely to experience moderate or severe myalgia compared to mild myalgia. None of the other serology tests for dengue, Legionella, Mycoplasma, or Leptospira were consistent with recent infection. Sarcocystis spp. were not detected by PCR in any water samples.

The authors conclude that the similarity of the symptoms and clustered time of onset suggests that all affected persons had muscular sarcocystosis. This was the largest human outbreak of sarcocystosis ever reported, with the specific Sarcocystis species identified. The largely nonspecific clinical features of this illness suggest that S. nesbitti may be an under diagnosed infection in the tropics. The study was published on May 22, 2014, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

University of Malaya
Vircell
Fujirebio Inc.




Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.